About Pond Capital
Pond Capital is a venture capital firm founded in 2012. It is primarily based out of Boston, United States. As of Feb 2016, Pond Capital has invested in 19 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to HealthTech and Food and Agriculture Tech. Most recently it participated in the $***** Series A round of Constant Therapy Health Overall, Pond Capital portfolio has seen 1 IPO and 8 acquisitions including key companies like Constant Therapy Health, Kinsa and kaleo. A lot of funds co-invest with Pond Capital, with names like Golden Seeds sharing a substantial percentage of its portfolio. Pond Capital has team of 2 people including 2 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A
Portfolio IPOs
Portfolio Soonicorns
Pond Capital's List of Top Investments
Pond Capital has a portfolio of 19 companies. Their most notable investments include Constant Therapy Health and Kinsa.Their portfolio spans across and United States. They have invested in Life Sciences, HealthTech, Food and Agriculture Tech and 5 other sectors, across stages such as Series A stage. Here is the list of top investments by Pond Capital:
Provider of an AI-based online health information platform for brain & mental health. It provides a mobile app that helps to improve care, reduce costs, and help people reach new heights of recovery. By combining AI it delivers personalized brain exercises that can help people reignite their cognitive, speech, and language abilities. It helps to monitor aphasia, dementia, traumatic brain injury, and many more.
Key facts about Constant Therapy Health
- Founded Year: 2013
- Location: Newton (United States)
- Stage: Acquired
- Total Funding till date: $2.84M
- Employee Count: 19 as on Jul 01, 2024
- Investors: Kapor Capital, NXT Ventures and 11 Others
- Latest Funding Round: Series A, Feb 01, 2016, $*****
- Highlight: Acquired
2. Kinsa
Provider of thermometer and mobile-based application for tracking the symptoms of fever. It offers a connected device and app for the users to monitor their fever-related symptoms such as cough, runny nose, sore throat, chills, body aches, and others. Also, it offers teleconsultation services and medication adherence management solutions for users.
Key facts about Kinsa
- Founded Year: 2012
- Location: San Francisco (United States)
- Stage: Acquired
- Total Funding till date: $29.1M
- Employee Count: 103 as on Jul 01, 2024
- Investors: Bayrock, GSR Ventures and 24 Others
- Latest Funding Round: Series B, Dec 23, 2016, $*****
- Highlight: Acquired
3. BiOWiSH
Biotechnology solutions for agriculture, aquaculture, and environmental management industries. We provide innovative biotechnology solutions, working with key officials and institutions globally to understand customer needs and develop solutions that fit current practices. We focus on delivering scientifically proven solutions for modern agriculture and environmental sustainability. Our offerings improve soil health, crop yields, and aquaculture practices. We are dedicated to creating resilient, regenerative agriculture systems that nourish both people and the planet. We lead the transition to biologically enhanced efficiency fertilizers, collaborating with the fertilizer industry to increase crop production sustainably, economically, and with a reduced carbon footprint. Our technology is natural and non-GMO, safe for people, plants, and animals, driving the future of biological solutions.
Key facts about BiOWiSH
- Founded Year: 2007
- Location: Cincinnati (United States)
- Stage: Series B
- Total Funding till date: $39.6M
- Employee Count: 32 as on Dec 31, 2023
- Investors: Saturn Partners, Pond Capital and 2 Others
- Latest Funding Round: Conventional Debt, Aug 17, 2023, $*****
- Highlight: Editors' Pick
Provider of MRI-based diagnostic software for cardiac disease. It has developed three products SENC calculates cardiac strain in a single heartbeat, eliminating the need to hold the breath, HARP is an FDA-cleared software that automatically analyzes tagged MRI images and measures cardiac function and VIRTUE provides a suite of tools to view and analyze cardiac images.
Key facts about Myocardial Solutions
- Founded Year: 2002
- Location: Morrisonville (United States)
- Stage: Series B
- Total Funding till date: $33.9M
- Employee Count: 20 as on Dec 31, 2022
- Investors: Pond Capital
- Latest Funding Round: Series B, Jun 29, 2023, $*****
- Highlight: Editors' Pick
5. kaleo
Innovating drug-device combinations and auto-injector technology for patient security and peace of mind. The company is a global leader focused on redefining medical technologies with innovative solutions. They specialize in drug-delivery device technology and auto-injector innovation, providing patients with security and peace of mind through human ingenuity. The Aerio™ Auto-Injector Platform offers flexibility across disease categories and environments, incorporating Human Factors Engineering and fully automated manufacturing. They partner with pharmaceutical and government agencies, offering custom-designed drug-delivery devices. Their marketed auto-injector medicines are designed to be easy-to-use for urgent medical needs. The company is committed to integrity, compliance, and improving quality of life and strengthening global health security.
Key facts about kaleo
- Founded Year: 2005
- Location: Richmond (United States)
- Stage: Acquired
- Employee Count: 220 as on Dec 31, 2020
- Investors: Hercules Capital, PDL Biopharma and 3 Others
- Latest Funding Round: Conventional Debt, Apr 07, 2014, $*****
- Highlight: Acquired
Pond Capital's Investments by Stage
Pond Capital has made 1 investment in Series A stage with an average round size of $2M.Pond Capital's Investments by Sector
Pond Capital has a portfolio focused on HealthTech. Notably, it has invested in 17 Tech companies, 14 Enterprise (B2B) companies, 7 Software companies and at least 3 companies focusing on Consumer (B2C).Pond Capital's Investments by Geography
Pond Capital has made most investments in United States (1).Pond Capital's recent investments
Pond Capital has not made any investment in 2026 so far.Here are the most recent investments by Pond Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Feb 01, 2016 | United States | Series A | 3318 | [+3] |
IPOs and Publicly Listed companies in Pond Capital's Portfolio
1 of Pond Capital's portfolio company became public - Tornier.Here are Pond Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
- | - | - | 1834 |
Acquired companies in Pond Capital's Portfolio
8 companies from Pond Capital's portfolio have been acquired. The most recent acquisition was Kinsa in Mar 2024 by Healthy Together for $*****.Here are Pond Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 05, 2024 | - | - | 7687 | |
Nov 29, 2021 | - | - | 8164 | |
May 31, 2017 | Feb 01, 2016 | Series A | 5250 | |
Apr 25, 2016 | - | - | 6126 | |
Oct 04, 2015 | - | - | 7941 |
Team profile of Pond Capital
Pond Capital has a team of 2 members including 2 Partners located in United States. Pond Capital's team does not sit on the board of any company as of now.Co-investors of Pond Capital
Over the past 10 years, 7 investors have co-invested in Pond Capital's portfolio companies. This includes funds and angels.
- Invested before Pond Capital: Kapor Capital, Boston University and 2 others have invested in rounds before Pond Capital. There is 1 company where Kapor Capital has invested before Pond Capital and 1 company where Boston University has invested before Pond Capital.
- Top Co-investors of Pond Capital: 3 investors entered a company along with Pond Capital. These include investors like Golden Seeds (1 company).
Recent News related to Pond Capital
•
Constant Therapy Secures $2 Million in Series A FundingYahoo•Feb 16, 2016•Constant Therapy Health, Golden Seeds, Kapor Capital, Launchpad Venture Group and 4 others
